Table 1.
PA | PI | Activity |
---|---|---|
0.952 | 0.001 | Inhibitor of 4-nitrophenol 2-monooxygenase |
0.952 | 0.003 | HIF1A expression inhibitor |
0.947 | 0.004 | Agonist of membrane integrity |
0.943 | 0.002 | Inhibitor 27-hydroxycholesterol 7α-monooxygenas |
0.938 | 0.002 | Kinase inhibitor |
0.933 | 0.002 | Inhibitor of colestanetriol 26-monooxygenase |
0.929 | 0.003 | Anaphylatoxin receptor antagonist |
0.914 | 0.003 | Inhibitor of membrane permeability |
0.913 | 0.004 | Chlordecone reductase inhibitor |
0.913 | 0.009 | CYP2C12 substrate |
0.903 | 0.002 | CYP2B5 substrate |
0.895 | 0.002 | Aryl-alcohol dehydrogenase (NADP+) inhibitor |
0.893 | 0.002 | CYP1A2 inducer |
0.874 | 0.014 | Aspulvinone dimethylallyltransferase inhibitor |
0.872 | 0.002 | Inhibitor of P-benzoquinone reductase (NADPH) |
0.857 | 0.004 | Inhibitor of 2-dehydropantoate 2-reductase |
0.857 | 0.006 | Aldehyde oxidase inhibitor |
0.854 | 0.003 | CYP1A inducer |
0.850 | 0.012 | Methylenetetrahydrofolate reductase inhibitor (NADPH) |
0.849 | 0.004 | Vasoprotector |
0.848 | 0.002 | CYP2A4 substrate |
0.829 | 0.002 | Quercetin 2.3-dioxygenase inhibitor |
0.829 | 0.002 | Inhibitor of Leukotriene-B4 20-monooxygenase |
0.820 | 0.005 | Inhibitor of complement factor D |
0.819 | 0.005 | Alkane 1-monooxygenase inhibitor |
0.814 | 0.003 | CYP2A11 substrate |
0.813 | 0.018 | CYP2J substrate |
0.813 | 0.022 | Testosterone 17beta-dehydrogenase (NADP+) inhibitor |
0.809 | 0.002 | CYP1A1 inducer |
0.807 | 0.003 | MAP kinase stimulant |
0.806 | 0.006 | Inhibitor of oxidoreductase |
0.804 | 0.005 | Peroxidase inhibitor |
0.803 | 0.003 | Total ecdysone 20-monooxygenase inhibitor |
0.801 | 0.004 | Inhibitor of Pin1 |
0.800 | 0.018 | mucous membrane protector |
0.795 | 0.004 | Antimutagenic |
0.787 | 0.006 | Inhibitor of nitrate reductase (cytochrome) |
Pa = (probability “to be active”), Pi = (probability “to be inactive”).